Nikhil C. Munshi, MD is the Kraft Family Chair and Professor of Medicine at the Harvard Medical School and the Director of Basic and Correlative Science, and Associate Director of the Jerome Lipper Myeloma Center at the Dana Farber Cancer Institute. He is an attending physician at the Brigham and Women’s Hospital, Harvard Medical School. Dr. Munshi received his medical degree from the S.S.G. Hospital and M.S. University, Baroda India. He completed a Research Fellowship in Medical Oncology at the Johns Hopkins Oncology Center in Baltimore, Maryland, and a clinical fellowship in hematology/oncology at the Indiana University Medical Center. Prior to joining Dana Farber, Dr. Munshi was Professor of Medicine and Director of the Clinical Gene Transduction Laboratory at the University of Arkansas.
Dr. Munshi's research focus spans both basic sciences to understand genomic changes in myeloma and elucidate molecular mechanisms driving the genomic instability in cancer, to translational approaches directed at improving diagnosis and prognosis as well as therapeutics. Dr Munshi’s clinical interests include CAR T-cell therapy in multiple myeloma and developing novel targeted therapeutics including novel antigen-directed and immune effector cell therapy/vaccine approaches.
He has over 500 peer-reviewed publications and book chapters. Dr Munshi has mentored over 70 junior faculty, post-doctoral fellows, medical residents, as well as medical and undergraduate students. A number of them are now independent scientists, physicians, and professionals. His grant support has included Program Project and SPORE grants from National Institutes of Health, and VA Research grants. He is the current President of the International Myeloma Society. He has received number of Awards including a Leukemia Society of America Scholar in Translational Research Award, the Dr. B.C. Roy National Award by the president of India in 2016 and the prestigious “Waldenstrom’s Award” for Most Distinguished Lifetime Achievement in Myeloma Research in 2013.